Figures & data
Table 1. Plant species used to treat diabetes mellitus in the Newcastle region (Kwa-Zulu Natal).
Table 2. Published information on the six identified plants.
Table 3. The inhibition of α-amylase activity (%) and EC50 (mg/ml) for each of the solvents used in this study at the minimum and maximum doses.
Table 4. The glucose quantity (mg) present after treatment of intestinal rat acetone powder and the α-glucosidase inhibitory activity (%) of different extracts of six plants used to treat and manage diabetes.
Watt JM, Breyer-Brandwijk MG. (1962). Medicinal and Poisonous Plants of Southern and Eastern Africa. Edinburgh: E & S Livingstone Limited Agbafor KN, Akubugwo EL. (2007). Hypocholesterolaemic effect of ethanolic extract of fresh leaves of Cymbopogon citratus (Lemongrass). Afr J Biotechnol 6:596–8 Adeneye AA, Agbaje EO. (2007). Hypoglycemic and hypolipidemic effects of fresh leaf aqueous extract of Cymbopogon citratus Stapf. in rats. J Ethnopharmacol 112:440–4 Leite JR, Seabra ML, Maluf E, et al. (1986). Pharmacology of lemongrass (Cymbopogon citratus stapf) III. Assessment of eventual, toxic, hypnotic and anxiolytic effects on humans. J Ethanopharmacol 17:75–83 Smith BD. (1997). The initial domestication of Cucurbita pepo in the Americas 10,000 years ago. Science 276:932–4 Caili F, Quanhong L. (2006). A review on pharmacological activities and utilization technologies of pumpkin. Plant Food Hum Nutr 61:73–80 Quanhong L, Caili F, Yukui R, et al. (2005). Effects of protein-bound polysaccharide isolated from pumpkin on insulin in diabetic rats. Plant Food Hum Nutr 60:13–16 Peng H. (2002). Isolation and hypoglycaemic effect of pumpkin polysaccharides. Chin J Food Sci 23:260–2 Zhang YJ. (2001). Study on extraction and separation of pumpkin polysaccharide and its glucatonic effect. Food Sci Technol 5:15–16 Von Breitenbach F. (1965). The Indigenous Trees of Southern Africa. Pretoria: Government Printer Hutchings A, Scott AH, Lewis G, Cunningham A. (1996). Zulu Medicinal Plants: An Inventory. Pietermaritzburg: University of Natal Press Mahomed IM, Ojewole JAO. (2003). Hypoglycaemic effects of Hypoxis hemerocallidea corm (African potato) aqueous extract in rats. Method Find Exp Clin 25:617–23 Ojewole JAO. (2006). Antinociceptve, anti-inflammatory and antidiabetic properties of Hypoxis hemerocallidea Fisch. & C.A. Mey. (Hypoxidaceae) corm “African potato” aqueous extract in mice and rats. J Ethnopharmacol 103:126–34 Ojewole JAO. (2002). Hypoglycaemic effect of Clausenia anisata (Wild) Hook methanolic root extract in rats. J Ethnopharmacol 81:231–7 Barceloux DG. (2009). Cinnamon (Cinnamomum species). Disease-a-Month 55:327–35 Dugoua J, Seely D, Perri D, et al. (2007). From type 2 diabetes to antioxidant activity: A systematic review of the safety and efficacy of common and cassia cinnamon bark. Can J Physiol Pharm 85:837–47 Khan A, Safdar M, Ali Khan MM, et al. (2003). Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetic Care 26:3215–18 Mang B, Wolters M, Schmitt B, et al. (2006). Effects of a cinnamon extract on plasma glucose HbAIc and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 36:340–4 Pham AQ, Helen-Kourlas BS. Pham DQ. (2007). Cinnamon supplementation in patients with type 2 diabetes mellitus. Pharmacotherapy 27:595–9 Lees HS. (2002). Inhibitory activity of Cinnamomum cassia bark-derived component against rat lens aldose reductase. J Pharm Pharm Sci 5:226–30